Klick CEO and Co-founder, Leerom Segal, sits down for a thoughtful conversation with Ray Dalio, author of Principles: Life & Work, at Summit LA. The pair discuss collective decision-making, idea meritocracy, failing well, and more.

Beyond the standard labs and radiology, exponential technologies are enabling new forms of sensing and diagnostics. Watch Leerom Segal and Kamran Shah talk about decoding the opportunities that machine vision promises over the decade ahead.

Godfrey Nazareth sits down with Ron Cohen for an in-depth conversation of the insights explored at Exponential Medicine 2018.

Leerom Segal and Dr. John Brownstein share their thoughts on the macrotrends taking shape at the intersection of voice and health.

Highlights from the 2018 Muse New York event.

Klick CEO Leerom Segal moderates an intimate conversation with former First Lady Michelle Obama where they discuss life after the White House, challenging society's expectations of you, and insights from years in the public eye with the MUSE New York guests.

Vinod Khosla, renowned silicon valley investor, talks with Dr. Daniel Kraft about opportunities in medicine.

Watch Arianna Huffington talk about her latest book on the science, history, and mystery behind the sleep revolution.

Mette Dyhrberg speaks to the power of environmental data over biomarkers during the MyMee program.

Anne Weiler looks at the potential benefits of accessibility in voice, while also addressing the boundaries that currently exist.

Alex Kumar walks us through a systems approach to viewing healthcare challenges to find unique solutions.

Leroy Hood talks with us about some of the key learnings and insights that were explored at Exponential Medicine 2016.

Lauren Steingold talks with us about the key learnings and insights that were explored at HLTH 2018.

Dr. Ron Cohen argues that the pharmaceutical industry's public perception could improve through transparent, value-driven statements.

Paul Irving talks with us about the key learnings and insights that were explored at HLTH 2018.

Larry Smarr talks with us about some of the key learnings and insights that were explored at Exponential Medicine 2016.

Can we define a limited set of markers we can use very inexpensively and reproducibly, to continually monitor our production of new drugs, and identify from a drop of patient's blood, before we manufacture their cells in that expensive process? Mark Bonyhadi foresees a future in which CAR T-Cells unlock that possibility.

Dr. Jay Parkinson argues that by taking the complexity out of billing, we'll change the structure and function of care tech for the better.

John Sculley talks with us about the key learnings and insights that were explored at Summit At Sea 2016.

John Mattison talks with us about some of the key learnings and insights that were explored at Exponential Medicine 2017.

John Brownstein addresses the opportunity and challenge of big data and how it will impact the future of healthcare delivery.

Neil Jacobstein talks with us about some of the key learnings and insights that were explored at Exponential Medicine 2017.

Dr. Shafi Ahmed discusses the vast power that voice tech has to transform operations for surgeons with real time advice and access to medical research.

Marc Goodman talks about hacking in the medical world, and how to protect yourself from exposing medical data to criminals.

Neil Jacobstein talks with us about some of the key learnings and insights that were explored at Exponential Medicine 2017.

Dr. Reena Pande and Pamela Greenberg talk with us about their newly published white paper and other insights that were explored at HLTH 2018.

Robert Hariri and Peter Diamandis present on the role of stem cells and regenerative medicine in the next evolution of human health, and why their objective is to ensure you to die young, as old as possible.

The study of the microbiome has become an increasingly important topic in modern medicine. Learn from Larry Smarr on what the microbiome is, what it means for modern medicine, and some of the ways it is going to change the future of treatment.